Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0.08Sales per Share
VS
Market
Sector
Industry
History
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information
Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARBUTUS BIOPHARMA CORP - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABUS - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 15.42M | 1 | 191.55M | $ 0.08 |
| 3/31/2025 | $ 6.4M | 1 | 190.71M | $ 0.03 |
| 12/31/2024 | $ 6.17M | 1 | 185.61M | $ 0.03 |
| 9/30/2024 | $ 6.74M | 1 | 189M | $ 0.04 |
| 6/30/2024 | $ 10.06M | 1 | 188.04M | $ 0.05 |
| 3/31/2024 | $ 12.99M | 1 | 175.63M | $ 0.07 |
| 12/31/2023 | $ 18.14M | 1 | 165.96M | $ 0.11 |
| 9/30/2023 | $ 22.24M | 1 | 167.51M | $ 0.13 |
| 6/30/2023 | $ 23.54M | 1 | 166.06M | $ 0.14 |
| 3/31/2023 | $ 33.13M | 1 | 161.64M | $ 0.2 |
Key Performance Insights, Last 5 Years
- ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) SPS stands at $ 0.08.
- Over the past 5 years, ARBUTUS BIOPHARMA CORP's average SPS has been $ 0.12.
- The median SPS for ARBUTUS BIOPHARMA CORP during this period was $ 0.1
- ARBUTUS BIOPHARMA CORP reached its highest SPS over the past 5 years at $ 0.26.
- The lowest SPS recorded by ARBUTUS BIOPHARMA CORP in the same timeframe $ 0.03
ARBUTUS BIOPHARMA CORP's SPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SPS Benchmarks
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for ARBUTUS BIOPHARMA CORP is calculated as follows: Revenues [ $ 6.15M ] / (Shares WA [ 79.49M ] * Share Factor [ 1 ])
(=) SPS [ $ 0.08 ] ABUS - Sales per Share, Last 5 years
$ 0.03
Minimum
Dec 31, 2024
$ 0.26
Maximum
Dec 31, 2022
$ 0.12
Average
$ 0.1
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.53 with a standard deviation of $ 13.59.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.64K |
|---|---|
| min | $ -18.02 |
| max | $ 54.75 |
| average | $ 11.53 |
| median | $ 5.88 |
| std | $ 13.59 |